Suppr超能文献

对分解骨骼组织进行毒理学分析以鉴别药物暴露模式。第二部分:阿米替林和西酞普兰。

Discrimination between patterns of drug exposure by toxicological analysis of decomposed skeletal tissues. Part II: Amitriptyline and citalopram.

机构信息

1Department of Forensic Science, Laurentian University, 935 Ramsey Lake Road, Sudbury, ON, Canada P3E 2C6.

出版信息

J Anal Toxicol. 2013 Oct;37(8):565-72. doi: 10.1093/jat/bkt078. Epub 2013 Aug 28.

Abstract

Decomposed bone and plasma samples of rats exposed to amitriptyline (AMI) and citalopram (CIT) under different dosing patterns were analyzed. Wistar rats received one acute dose (120 mg AMI/kg and 40 mg CIT/kg; n = 5) or two doses (40 mg AMI/kg and 13 mg CIT/kg, n = 5) 40 min apart. After collection of perimortem blood, the rats were euthanized and placed outdoors to decompose to skeleton. Recovered bone was ground and subjected to methanolic extraction. Bone extracts and plasma samples underwent solid-phase extraction and were analyzed using ultra-high-performance liquid chromatography. Concentrations of drugs and the primary metabolites [nortriptyline (NORT), desmethylcitalopram (DMCIT) and didesmethylcitalopram (DDMCIT)] were expressed as mass-normalized response ratios (RR/m). Concentrations (RR/m) of AMI, CIT and metabolites did not differ significantly between exposure types in plasma and all bone types examined or for the pooled bone samples (P > 0.05). However, ratios of concentrations of NORT to those of AMI differed significantly between exposure patterns for all bone types except for rib (P < 0.05). Values of DMCIT/CIT differed significantly between exposure patterns in rib, pelvi and femora (P < 0.05). Values of DDMCIT/CIT did not differ significantly between exposure types (P > 0.05), while those of DDMCIT/DMCIT were significantly different for all bones except the vertebrae and rib (P < 0.05).

摘要

对暴露于阿米替林(AMI)和西酞普兰(CIT)不同剂量模式下的大鼠的分解骨和血浆样本进行了分析。Wistar 大鼠接受单次急性剂量(120mg AMI/kg 和 40mg CIT/kg;n=5)或两次剂量(40mg AMI/kg 和 13mg CIT/kg,间隔 40 分钟;n=5)。在采集濒死期血液后,处死大鼠并将其放置在户外分解至骨骼。回收的骨骼被研磨并进行甲醇提取。骨骼提取物和血浆样品进行固相萃取,并用超高效液相色谱法进行分析。药物和主要代谢物(去甲替林(NORT)、去甲基西酞普兰(DMCIT)和双去甲基西酞普兰(DDMCIT))的浓度以质量归一化响应比(RR/m)表示。在血浆和所有检查的骨骼类型以及混合骨骼样本中,AMI、CIT 和代谢物的浓度(RR/m)在暴露类型之间没有显著差异(P>0.05)。然而,除了肋骨之外,所有骨骼类型的 NORT 与 AMI 的浓度比在暴露模式之间存在显著差异(P<0.05)。肋骨、骨盆和股骨中的 DMCIT/CIT 值在暴露模式之间存在显著差异(P<0.05)。DDMCIT/CIT 值在暴露类型之间没有显著差异(P>0.05),而除了椎骨和肋骨之外,所有骨骼的 DDMCIT/DMCIT 值都存在显著差异(P<0.05)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验